Lindbrook Capital, LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 127 filers reported holding ANI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,793
+7.9%
1170.0%0.00%0.0%
Q2 2023$6,298
+35.5%
1170.0%0.00%0.0%
Q1 2023$4,647
-7.6%
117
-6.4%
0.00%0.0%
Q4 2022$5,029
+25.7%
1250.0%0.00%0.0%
Q3 2022$4,0000.0%1250.0%0.00%0.0%
Q2 2022$4,000
+33.3%
125
+13.6%
0.00%
Q1 2022$3,000
-81.2%
110
-45.0%
0.00%
-100.0%
Q2 2019$16,0002000.01%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders